News | January 26, 2022
Torrent Pharmaceuticals consolidated PAT at Rs 249 cr
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Biocon has reported consolidated financial results for the period ended December 31, 2021
The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
_256_384.jpg)
Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve
Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021
In addition to its favourable activity profile, IBIO123 is formulated for administration by inhalation providing an efficient, rapid and non-invasive delivery method into the lungs via the respiratory tract
Partnering to build biosynthesis processes and a pharmaceutical production platform
The Subject Expert Committee has recommended grant of permission to conduct Phase 3 trials under certain conditions
Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
Subscribe To Our Newsletter & Stay Updated
